Synthetic peptides that turn off specific immune cells: Began Phase II trial in 90 patients

The Immune Response Corp. (IMNR), Carlsbad, Calif. Product: Synthetic peptides that turn off specific immune cells Indication: Psoriasis Status: Began Phase II trial in 90 patients ...